ECMO – Covid-19 in German ICUs

ECMO - Covid-19 in German ICUs

ECMO is increasingly preferred to invasive ventilation in German ICUs in 2021.

We have analyzed the numbers of Robert Koch Institute and DIVI Intensive Care Register for 2021 to identify the treatment of Covid-19 patients in German ICUs. The data shows decreasing use of invasive ventilation and increasing use of High Flow, NIV and particularly ECMO (extracorporeal membrane oxygenation).

We observe COVID being a tailwind for ECMO, just as H1N1 was a driver in 2009. Still, there are barriers to wider adoption of the method. It requires more clinical personnel per patient than ventilation. Good practice for this treatment requires 1-to-1 nursing for each case, as patient mobility is important. Shortage of personnel is a major barrier. In addition, well-trained intensivists are needed to perform the vessel cannulation.

Share:

Related Insights

Defibrillation Market

Defibrillation Market

Defibrillation market size was ~$4bn, with projected ~2% CAGR to 2030. In the market size split, devices account for about 60%, consumables 30% and accessories

Reflection on Vyaire Medical

Reflection on Vyaire Medical

Reflection on Vyaire Medical: Vyaire Medical was formed in October 2016 through a joint venture between Becton Dickinson and Apax Partners, a global private equity

The Strategists Network is an alliance of experienced executives offering management consulting services.

ECMO – Covid-19 in German ICUs

ECMO – Covid-19 in German ICUs

ECMO – Covid-19 in German ICUs